APRE vs EQR · $10.4M cap vs P/E 26, $26.37B cap
Aprea Therapeutics Inc (APRE) versus Equity Residential (EQR) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Equity Residential (EQR) is a reit - residential company listed on US.
APRE does not have a complete income-statement cache yet.
EQR does not have a complete income-statement cache yet.
APRE currently screens at market cap $10.4M. EQR currently screens at market cap $26.37B and trailing P/E 25.7.
Not investment advice. Open the APRE and EQR stock pages for the full models.
Not investment advice.